Related Experiment Video
Updated: Mar 12, 2026

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
Emergent Challenges in Determining Costs for Economic Evaluations
Josephine C Jacobs1, Paul G Barnett2,3
1VA Health Economics Resource Center, 795 Willow Rd. (152), Menlo Park, CA, 94025, USA. josephine.jacobs@va.gov.
Accurate healthcare cost determination requires understanding various methods like micro-costing and activity-based costing. Evolving healthcare trends present new challenges and opportunities for precise economic evaluations.
Area of Science:
- Health Economics
- Healthcare Management
- Cost Analysis
Background:
- Healthcare cost determination is crucial for economic evaluations.
- Recent developments in healthcare delivery impact costing methodologies.
- Existing guidelines offer frameworks for implementing costing methods.
Purpose of the Study:
- To describe methods for determining healthcare costs.
- To analyze how recent healthcare developments affect cost determination.
- To identify strengths and weaknesses of principal costing methods.
Main Methods:
- Literature review to identify strengths and weaknesses of micro-costing, activity-based costing, charge-based costing, and gross costing.
- Scoping review to identify key healthcare delivery trends and associated costing issues.
- Analysis of six major healthcare trends impacting costing methodology.
Main Results:
- Bottom-up costing is accurate but resource-intensive; top-down approaches are often more feasible.
- Six key healthcare trends (payment reform, decentralized care, telehealth, new technology, privacy, guideline implementation) significantly affect costing.
- Certain costs (physician services, facility costs, innovation development, patient/caregiver, indirect organizational) are difficult to measure and often overlooked.
Conclusions:
- Standardized methods are needed for social welfare and productivity cost determination.
- Technological advances may aid future cost determination.
- Shift to capitated payments, less restrictive care settings, and privacy concerns may hinder future cost determination.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
13:04Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
Published on: September 19, 2012
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Confounding in Epidemiological Studies
Assumptions of Survival Analysis
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...